By Anastasia Stefanidou, Communications Officer, Biochemical Society
In the spirit of this year’s Peer Review Week (11–17 September 2017), the Editors-in-Chief of Portland Press journals, give us their thoughts on the essential role that peer review plays in maintaining scientific quality.
Continue reading Peer Review: an Editor-in-Chief’s perspective
By Rosalind Brown, Centre for Clinical Brain Sciences, University of Edinburgh
Most people will have heard of Alzheimer’s disease, but fewer people are aware of cerebral small vessel disease (SVD), a silently progressing disease of ageing responsible for nearly half of all cases of dementia along with a large percentage of strokes. The global health impact of SVD is huge and while a small number of genetic mutations have been identified as causing some forms, for the majority of cases the cause is uncertain.
Continue reading Spotlight on cerebral small vessel disease
By James Brown, Education and Public Engagement Officer, Biochemical Society
In April, I was lucky enough to be able to attend the Experimental Biology conference in Chicago.
Continue reading Experimental Biology 2017 – a showcase for interdisciplinary collaboration
By Ralitsa Madsen, Institute of Metabolic Science, Cambridge, UK
Iris, the Greek Goddess messenger between humans on Earth and the Gods on Mount Olympus, has made an entry into human biology by providing inspiration for the name of a skeletal muscle-derived hormone. Irisin belongs to the class of myokines, which are molecules released by skeletal muscle in response to exercise and act as messengers to other tissues, including liver, fat and the brain. Given the beneficial effects of exercise, particularly in the context of obesity and Type 2 Diabetes, major efforts have been invested into discovering myokines of potential therapeutic value. Irisin seems to have it all, with multiple animal studies confirming its metabolic benefits such as lowering of blood glucose and lipid levels. Continue reading “The metabolic benefits of exercise”